<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00162578</url>
  </required_header>
  <id_info>
    <org_study_id>LMR4</org_study_id>
    <nct_id>NCT00162578</nct_id>
  </id_info>
  <brief_title>Vancomycin Concentration in Cerebrospinal Fluid During Pneumococcal Meningitis</brief_title>
  <official_title>Vancomycin Concentration in Cerebrospinal Fluid During Pneumococcal Meningitis Treated With Dexamethasone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adding vancomycin to the antibiotic regimen is recommended for the treatment of pneumococcal&#xD;
      meningitis in adults. Use of dexamethasone as adjunct therapy has proved to reduce mortality&#xD;
      and neurologic sequelae in adult patients with pneumococcal meningitis. However, use of&#xD;
      dexamethasone may impair penetration of vancomycin in cerebrospinal fluid. In a purely&#xD;
      observational manner, we thought to measure blood and CSF concentrations of vancomycin in&#xD;
      adult patients with pneumococcal meningitis, treated with vancomycin, third-generation&#xD;
      cephalosporin and dexamethasone.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Because of a considerable increase in streptococcus pneumoniae meningitis with penicillin&#xD;
      nonsusceptible strains, it is now largely recommended to add vancomycin to the&#xD;
      third-generation cephalosporin antibiotic regimen. It has also been recently shown that use&#xD;
      of dexamethasone reduces mortality and unfavorable outcome in adults with pneumococcal&#xD;
      meningitis. However, concern has arisen, that dexamethasone may impair penetration of&#xD;
      vancomycin in cerebrospinal fluid.&#xD;
&#xD;
      We therefore thought to measure in a purely observational study, blood and CSF vancomycin&#xD;
      concentrations in adult patients with pneumococcal meningitis hospitalized in medical&#xD;
      intensive care unit that received third-generation cephalosporin, vancomycin and&#xD;
      dexamethasone. The aim of the study was to observe whether or not sufficient concentrations&#xD;
      of vancomycin could be measured in the CSF despite the concomitant use of dexamethasone.&#xD;
      Patients were cared for in a perfectly routine manner. There was no randomization. All&#xD;
      patients received routine, recommended care (IDSA guidelines). There was no invasive&#xD;
      procedure. Dexamethasone was administered according to the de Gans study (NEJM 2002). In&#xD;
      these patients with severe meningitis, a second lumbar puncture was performed as&#xD;
      recommended(IDSA Guidelines, CID 2004). At the same time, peripheral blood was taken. In both&#xD;
      samples, vancomycin concentration was determined.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2002</start_date>
  <completion_date type="Actual">November 2005</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">14</enrollment>
  <condition>Pneumococcal Meningitis</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults (&gt; 18 yr) with suspicion of pneumococcal meningitis requiring intensive care&#xD;
             unit&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Allergy to one of the antibiotics used in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Damien Ricard, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Didier DREYFUSS, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service de Réanimation Médicale, CHU Louis Mourier</name>
      <address>
        <city>Colombes</city>
        <zip>92700</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Réanimation Médicale, CHU Bichat</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Réanimation Médicale, CHI Poissy-St-Germain</name>
      <address>
        <city>Poissy</city>
        <zip>78300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004 Nov 1;39(9):1267-84. Epub 2004 Oct 6.</citation>
    <PMID>15494903</PMID>
  </reference>
  <reference>
    <citation>de Gans J, van de Beek D; European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002 Nov 14;347(20):1549-56.</citation>
    <PMID>12432041</PMID>
  </reference>
  <reference>
    <citation>Auburtin M, Porcher R, Bruneel F, Scanvic A, Trouillet JL, Bédos JP, Régnier B, Wolff M. Pneumococcal meningitis in the intensive care unit: prognostic factors of clinical outcome in a series of 80 cases. Am J Respir Crit Care Med. 2002 Mar 1;165(5):713-7.</citation>
    <PMID>11874820</PMID>
  </reference>
  <reference>
    <citation>Viladrich PF, Gudiol F, Liñares J, Pallarés R, Sabaté I, Rufí G, Ariza J. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother. 1991 Dec;35(12):2467-72.</citation>
    <PMID>1810180</PMID>
  </reference>
  <verification_date>July 2007</verification_date>
  <study_first_submitted>September 9, 2005</study_first_submitted>
  <study_first_submitted_qc>September 9, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2005</study_first_posted>
  <last_update_submitted>July 20, 2007</last_update_submitted>
  <last_update_submitted_qc>July 20, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 23, 2007</last_update_posted>
  <keyword>pneumococcal meningitis</keyword>
  <keyword>intensive care unit</keyword>
  <keyword>vancomycin</keyword>
  <keyword>dexamethasone</keyword>
  <keyword>drug diffusion in cerebrospinal fluid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meningitis, Pneumococcal</mesh_term>
    <mesh_term>Meningitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

